{"id":864560,"date":"2025-06-27T08:34:55","date_gmt":"2025-06-27T12:34:55","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/"},"modified":"2025-06-27T08:34:55","modified_gmt":"2025-06-27T12:34:55","slug":"helius-medical-technologies-announces-reverse-stock-split-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/","title":{"rendered":"Helius Medical Technologies Announces Reverse Stock Split"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEWTOWN, Pa., June  27, 2025  (GLOBE NEWSWIRE) &#8212; Helius Medical Technologies, Inc. (Nasdaq:HSDT) (\u201cHelius\u201d or the \u201cCompany\u201d), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced today a 1-for-50 reverse split of its Class A common stock, par value $0.001 (\u201ccommon stock\u201d), effective at 5:00 pm Eastern time on June 30, 2025. Beginning on July 1, 2025, the Company\u2019s common stock will trade on The Nasdaq Capital Market on a split adjusted basis.<\/p>\n<p align=\"justify\">At the Company\u2019s special meeting of stockholders on May 23, 2025, the stockholders approved a proposal to amend the Company\u2019s Certificate of Incorporation to effect a reverse split of the Company\u2019s outstanding common stock at a ratio in the range of 1-for-2 to 1-for-250 to be determined at the discretion of our Board of Directors, whereby each outstanding 2 to 250 shares would be combined, converted and changed into 1 share of common stock, to enable the Company to comply with the Nasdaq Stock Market\u2019s continued listing requirements. Subsequently, the Board of Directors approved the reverse split at a ratio of 1-for-50. As a result of the reverse stock split, every 50 shares of the company&#8217;s common stock issued and outstanding will be automatically converted into one share of common stock, with no change in the $0.001 par value per share or authorized number of shares of common stock.<\/p>\n<p align=\"justify\">Upon effectiveness, the reverse stock split will cause a reduction in the number of shares of common stock outstanding and issuable upon the conversion of the Company\u2019s outstanding stock options and warrants in proportion to the ratio of the reverse split and will cause a proportionate increase in the conversion and exercise prices of such stock options and warrants. Any fraction of a share of common stock that would be created as a result of the Reverse Stock Split will be rounded down to the next whole share and the stockholder will receive cash equal to the market value of the fractional share, determined by multiplying such fraction by the closing sales price of the Company\u2019s common stock as reported on Nasdaq on the last trading day before the Reverse Stock Split becomes effective (on a split-adjusted basis).<\/p>\n<p align=\"justify\">The Company\u2019s common stock will continue to trade on The Nasdaq Capital Market under the symbol \u201cHSDT.\u201d The new CUSIP number for the common stock following the reverse split is 42328V 876.<\/p>\n<p align=\"justify\">The number of authorized shares of the Company\u2019s common stock will remain at 150 million, while the number of outstanding shares will be reduced from approximately 33.8 million to approximately 0.7 million.<\/p>\n<p align=\"justify\">Additional information about the reverse stock split can be found in the Company\u2019s definitive proxy statement filed with the Securities and Exchange Commission on May 2, 2025, a copy of which is also available on the Company\u2019s website under the Investor Relations page.<\/p>\n<p align=\"justify\">\n        <strong>About Helius Medical Technologies, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain\u2019s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company\u2019s first commercial product is the Portable Neuromodulation Stimulator (PoNS<sup>\u00ae<\/sup>). For more information about PoNS or Helius Medical Technologies, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SICOAOeF4c0AC5KcrZBJ_pRnF5ZW0Zh87ngvKhCUhHJODghi4b4xY3jphDqT1k4ofkli6BwPeeKJ28P63yqoawU5CB1rGE_XxAC6k1y8-Byds5an7Nn8oPLRL6tb4abyRMckvnGtmSWQfrL3rii-psPQrttmUmcJAHsAYHVg3J6cfW2jtYoSXrf17pTOFqABhkYR6A25hjUM1yhY2Qj_hlVMU2nLKif1UaMkJ4whWyb_InQcKz8pe7iC0KJRJY_niuI3Goc7DOsSMOmfuM3E2ytaTyNaXRM3OoPKdkK6NVb4g6EG7ffNKdy1pRHiC1TTqVsS28oIII5aCn2Gb3j5bOaiswzd0OWoPAdAmryTN_Auvz51JcnRCwX-JcnpsQ_Cp52CtoX0s6kEaka0w6lYco2p6SfX439QQGlYMADPo4kQk1HvYaaKievzEYDQY74TWpub50Z4gGVBZhouNxGABatDmy2lV38E_TmvrFW9v05zV4yTSTEftn3aw7eOxpKKfET991GBU6WJOt64-PYB48nsdcON2rfMsDdSCYf0XMxoD-gxgz7AAA4wMH7gjRXcN8uh-jwSSV26bqvt2fINeT9B_0NBJrp15olWbaA2oLVgBscAFCcBysivPpAfai7VuyL__PX7uhDDiBQgGDIePa37QrgrWedOKi3CE976knw=\" rel=\"nofollow\" target=\"_blank\">www.heliusmedical.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Investor Relations Contact:<\/strong>\n      <\/p>\n<p>Philip Trip Taylor<br \/>Gilmartin Group<br \/>investorrelations@heliusmedical.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTQ1MyM3MDIxMTA5IzIwODIwMzE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YzUzODgzOGEtY2M1YS00NzA3LWExNzUtNGQ3MzNmMDQ3YWM2LTEwOTM2MDItMjAyNS0wNi0yNy1lbg==\/tiny\/Helius-Medical-Technologies-In.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEWTOWN, Pa., June 27, 2025 (GLOBE NEWSWIRE) &#8212; Helius Medical Technologies, Inc. (Nasdaq:HSDT) (\u201cHelius\u201d or the \u201cCompany\u201d), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced today a 1-for-50 reverse split of its Class A common stock, par value $0.001 (\u201ccommon stock\u201d), effective at 5:00 pm Eastern time on June 30, 2025. Beginning on July 1, 2025, the Company\u2019s common stock will trade on The Nasdaq Capital Market on a split adjusted basis. At the Company\u2019s special meeting of stockholders on May 23, 2025, the stockholders approved a proposal to amend the Company\u2019s Certificate of Incorporation to effect a reverse split of the Company\u2019s outstanding common stock at a ratio in the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Helius Medical Technologies Announces Reverse Stock Split&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-864560","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Helius Medical Technologies Announces Reverse Stock Split - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Helius Medical Technologies Announces Reverse Stock Split - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEWTOWN, Pa., June 27, 2025 (GLOBE NEWSWIRE) &#8212; Helius Medical Technologies, Inc. (Nasdaq:HSDT) (\u201cHelius\u201d or the \u201cCompany\u201d), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced today a 1-for-50 reverse split of its Class A common stock, par value $0.001 (\u201ccommon stock\u201d), effective at 5:00 pm Eastern time on June 30, 2025. Beginning on July 1, 2025, the Company\u2019s common stock will trade on The Nasdaq Capital Market on a split adjusted basis. At the Company\u2019s special meeting of stockholders on May 23, 2025, the stockholders approved a proposal to amend the Company\u2019s Certificate of Incorporation to effect a reverse split of the Company\u2019s outstanding common stock at a ratio in the &hellip; Continue reading &quot;Helius Medical Technologies Announces Reverse Stock Split&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-27T12:34:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTQ1MyM3MDIxMTA5IzIwODIwMzE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-announces-reverse-stock-split-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-announces-reverse-stock-split-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Helius Medical Technologies Announces Reverse Stock Split\",\"datePublished\":\"2025-06-27T12:34:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-announces-reverse-stock-split-3\\\/\"},\"wordCount\":557,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-announces-reverse-stock-split-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4NTQ1MyM3MDIxMTA5IzIwODIwMzE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-announces-reverse-stock-split-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-announces-reverse-stock-split-3\\\/\",\"name\":\"Helius Medical Technologies Announces Reverse Stock Split - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-announces-reverse-stock-split-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-announces-reverse-stock-split-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4NTQ1MyM3MDIxMTA5IzIwODIwMzE=\",\"datePublished\":\"2025-06-27T12:34:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-announces-reverse-stock-split-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-announces-reverse-stock-split-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-announces-reverse-stock-split-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4NTQ1MyM3MDIxMTA5IzIwODIwMzE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4NTQ1MyM3MDIxMTA5IzIwODIwMzE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/helius-medical-technologies-announces-reverse-stock-split-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Helius Medical Technologies Announces Reverse Stock Split\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Helius Medical Technologies Announces Reverse Stock Split - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/","og_locale":"en_US","og_type":"article","og_title":"Helius Medical Technologies Announces Reverse Stock Split - Market Newsdesk","og_description":"NEWTOWN, Pa., June 27, 2025 (GLOBE NEWSWIRE) &#8212; Helius Medical Technologies, Inc. (Nasdaq:HSDT) (\u201cHelius\u201d or the \u201cCompany\u201d), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced today a 1-for-50 reverse split of its Class A common stock, par value $0.001 (\u201ccommon stock\u201d), effective at 5:00 pm Eastern time on June 30, 2025. Beginning on July 1, 2025, the Company\u2019s common stock will trade on The Nasdaq Capital Market on a split adjusted basis. At the Company\u2019s special meeting of stockholders on May 23, 2025, the stockholders approved a proposal to amend the Company\u2019s Certificate of Incorporation to effect a reverse split of the Company\u2019s outstanding common stock at a ratio in the &hellip; Continue reading \"Helius Medical Technologies Announces Reverse Stock Split\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/","og_site_name":"Market Newsdesk","article_published_time":"2025-06-27T12:34:55+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTQ1MyM3MDIxMTA5IzIwODIwMzE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Helius Medical Technologies Announces Reverse Stock Split","datePublished":"2025-06-27T12:34:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/"},"wordCount":557,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTQ1MyM3MDIxMTA5IzIwODIwMzE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/","name":"Helius Medical Technologies Announces Reverse Stock Split - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTQ1MyM3MDIxMTA5IzIwODIwMzE=","datePublished":"2025-06-27T12:34:55+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTQ1MyM3MDIxMTA5IzIwODIwMzE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4NTQ1MyM3MDIxMTA5IzIwODIwMzE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/helius-medical-technologies-announces-reverse-stock-split-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Helius Medical Technologies Announces Reverse Stock Split"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/864560","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=864560"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/864560\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=864560"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=864560"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=864560"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}